Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Code:
NCT03685721
Conditions
Sickle Cell
PKLR Variants
Adenosine Triphosphate Activities
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Sickle Cell
PKLR Variants
Adenosine Triphosphate Activities
Study ID
NCT03685721
Start date
Oct 11, 2018
Status verified date
Aug 13, 2026
Completion date
Jul 1, 2027
Anticipated
Primary completion date
Jul 1, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Enrollment
800 participants
Anticipated
Arms
HbAS
Healthy control
SCD
Primary outcome measure
Central contacts
Locations
National Institutes of Health Clinical Center
Recruiting
Bethesda, Maryland, United States, 20892
Contacts
For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
800-411-1222prpl@cc.nih.govSponsor
National Heart, Lung, and Blood Institute (NHLBI)
Last update posted
Aug 17, 2026
Last verified
Aug 13, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Heart, Lung, and Blood Institute (NHLBI) on 2026-08-17.